Temasek subsidiary Ion to earn up to $1b by paring stake in South Korean firms

Temasek subsidiary Ion to earn up to $1b by paring stake in South Korean firms

Photo: Celltrion's Facebook page

Anuradha Subramanyan

06 March, 2018

celltrionCelltrion HealthcareIon InvestmentsTemasek Holdings

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Singapore

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.